Automated Contouring and Planning in Radiation Therapy: What Is ‘Clinically Acceptable’?

Hana Baroudi, Kristy K. Brock, Wenhua Cao, Xinru Chen, Caroline Chung, Laurence E. Court, Mohammad D. El Basha, Maguy Farhat, Skylar Gay, Mary P. Gronberg, Aashish Chandra Gupta, Soleil Hernandez, Kai Huang, David A. Jaffray, Rebecca Lim, Barbara Marquez, Kelly Nealon, Tucker J. Netherton, Callistus M. Nguyen, Brandon ReberDong Joo Rhee, Ramon M. Salazar, Mihir D. Shanker, Carlos Sjogreen, McKell Woodland, Jinzhong Yang, Cenji Yu, Yao Zhao

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Developers and users of artificial-intelligence-based tools for automatic contouring and treatment planning in radiotherapy are expected to assess clinical acceptability of these tools. However, what is ‘clinical acceptability’? Quantitative and qualitative approaches have been used to assess this ill-defined concept, all of which have advantages and disadvantages or limitations. The approach chosen may depend on the goal of the study as well as on available resources. In this paper, we discuss various aspects of ‘clinical acceptability’ and how they can move us toward a standard for defining clinical acceptability of new autocontouring and planning tools.

Original languageEnglish (US)
Article number667
JournalDiagnostics
Volume13
Issue number4
DOIs
StatePublished - Feb 2023

Keywords

  • artificial intelligence
  • quality assurance
  • radiotherapy treatment planning

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Automated Contouring and Planning in Radiation Therapy: What Is ‘Clinically Acceptable’?'. Together they form a unique fingerprint.

Cite this